Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Porphysome Nanoparticles for Imaging of Advanced Metastatic Gynaecological Cancers
NCT06977126Phase 1Recruiting
- Sponsor
- University Health Network
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of porphysome and 64Cu-porphysomes in gynecological cancer, sponsored by University Health Network. Primary endpoint: Incidence of Dose Limiting Toxicities at 1 year. Started Nov 2025; status: recruiting.
02
Drugs
porphysome64Cu-porphysomes
03
Conditions
gynecological cancer
Beyond the preview
Go deeper on NCT06977126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06977126.